Ergosterol isolated from the basidiomycete Pleurotus salmoneostramineus affects Trypanosoma cruzi plasma membrane and mitochondria

Abstract

BackgroundMajor drawbacks of the available treatment against Chagas disease (American trypanosomiasis) include its toxicity and therapeutic inefficiency in the chronic phase of the infection, which makes it a concern among neglected diseases. Therefore, the discovery of alternative drugs for treating chronic Chagas disease requires immediate action. In this work, we evaluated the mushroom Pleurotus salmoneostramineus in the search for potential antiparasitic compounds.MethodsFruit bodies of the basidiomycete Pleurotus salmoneostramineus were triturated and submitted to organic solvent extraction. After liquid-liquid partition of the crude extract, three fractions were obtained and the bioguided fractionation study was conducted to isolate the active metabolites. The elucidation of the chemical structure was performed using GC-MS and NMR techniques. The biological assays for antiparasitic activity were carried out using trypomastigotes of Trypanosoma cruzi and murine macrophages for mammalian cytotoxicity. The mechanism of action of the isolated compound used different fluorescent probes to evaluate the plasma membrane permeability, the potential of the mitochondrial membrane and the intracellular levels of reactive oxygen species (ROS).ResultsThe most abundant fraction showing the antiparasitic activity was isolated and chemically elucidated, confirming the presence of ergosterol. It showed anti-Trypanosoma cruzi activity against trypomastigotes, with an IC50 value of 51.3 μg/mL. The compound demonstrated no cytotoxicity against mammalian cells to the maximal tested concentration of 200 μg/mL. The mechanism of action of ergosterol in Trypanosoma cruzi trypomastigotes resulted in permeabilization of the plasma membrane, as well as depolarization of mitochondrial membrane potential, leading to parasite death. Nevertheless, no increase in ROS levels could be observed, suggesting damages to plasma membrane rather than an induction of oxidative stress in the parasite.ConclusionsThe selection of naturally antiparasitic secondary metabolites in basidiomycetes, such as ergosterol, may provide potential scaffolds for drug design studies against neglected diseases.Electronic supplementary materialThe online version of this article (doi:10.1186/s40409-017-0120-0) contains supplementary material, which is available to authorized users.

Triterpenes from Pholiota populnea as Cytotoxic Agents and Chemosensitizers to Overcome Multidrug Resistance of Cancer Cells

“… 14 Compound 6 was found to be identical in all of its spectroscopic characteristics with that of ergosterol. 15 3β-Hydroxyergosta-7,22-diene was detected in the n -hexane fraction with the use of an authentic standard.…”

Bioactive secondary metabolites from new endophytic fungus Curvularia. sp isolated from Rauwolfia macrophylla

“…Most of the current antifungal agents interfere with ergosterol-function in some way, either through inhibition of various steps in ergosterol biosynthesis (allylamines, azoles, morpholines) or by complexing directly with membrane ergosterol (polyenes). Biologically, ergosterol was reported to have several effective activities, for example it has an inhibitory effect on the activity of mucosal-type mast cells [40], anti- Trypanosoma cruzi activity against trypomastigotes (IC 50 51.3 μg/mL) [41], and antifungal activity as well. More recently, ergosterol derivatives were reported as Anti-tumor and Anti-angiogenic agents [42].…”

Second-generation pterocarpanquinones: synthesis and antileishmanial activity

“…Negative IV values correspond to depolarization of the mitochondrial membrane. The FCCP (Carbonyl cyanide- p -Trifluoromethoxyphenylhydrazone) 20 μM was used as positive control [ 25 ].…”